Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Equity Ratio (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Equity Ratio for 15 consecutive years, with 0.09 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio fell 80.59% year-over-year to 0.09, compared with a TTM value of 0.09 through Sep 2025, down 80.59%, and an annual FY2024 reading of 0.44, down 26.82% over the prior year.
  • Equity Ratio was 0.09 for Q3 2025 at Sanara MedTech, down from 0.36 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.91 in Q1 2021 and bottomed at 0.09 in Q3 2025.
  • Average Equity Ratio over 5 years is 0.63, with a median of 0.61 recorded in 2024.
  • The sharpest move saw Equity Ratio soared 60.62% in 2021, then tumbled 80.59% in 2025.
  • Year by year, Equity Ratio stood at 0.83 in 2021, then dropped by 17.49% to 0.68 in 2022, then dropped by 11.7% to 0.6 in 2023, then dropped by 26.82% to 0.44 in 2024, then plummeted by 80.42% to 0.09 in 2025.
  • Business Quant data shows Equity Ratio for SMTI at 0.09 in Q3 2025, 0.36 in Q2 2025, and 0.38 in Q1 2025.